Educational information: This article does not diagnose a condition or replace individualized medical care. Seek urgent or emergency care for concerning symptoms.

A symptom is a clue—not a diagnosis

Lower energy, reduced libido, changes in strength or body composition, erectile concerns, poor concentration, and slower recovery can lead men to wonder about testosterone. These symptoms deserve attention, but they are not specific to testosterone deficiency.

Sleep apnea, obesity, undernutrition, thyroid or pituitary conditions, medication effects, alcohol use, depression, chronic illness, and other factors can create similar patterns. The Endocrine Society’s July 2026 statement emphasizes that symptoms alone are not diagnostic and that reversible contributors should be considered before treatment.

Diagnosis should be confirmed before treatment

A responsible evaluation connects compatible symptoms with consistently low, accurately measured testosterone levels. When results are low or unexpected, repeat early-morning testing is commonly needed before calling the finding persistent.

Additional testing is selected according to the history and results—not ordered as a one-size-fits-all panel.

  • Review symptoms, timing, medications, supplements, sleep, alcohol use, and medical history
  • Confirm testosterone with properly timed repeat testing when indicated
  • Use LH and FSH to help distinguish testicular from pituitary or hypothalamic causes
  • Consider prolactin, thyroid, blood count, metabolic testing, or specialty evaluation when the clinical pattern supports it
  • Discuss benefits, limitations, risks, alternatives, and what treatment would actually be expected to improve

Fertility goals must come before the prescription

Exogenous testosterone can suppress the hormonal signals needed for sperm production. A man who is trying to conceive—or who may want biological children—should discuss that goal before beginning or changing testosterone therapy.

The Endocrine Society recommends against starting testosterone therapy in men planning fertility in the near term. Depending on the situation, semen analysis, reproductive-urology consultation, or a different treatment strategy may be appropriate.

Safety screening is individualized

Testosterone is not appropriate for every patient. The safety review may include hematocrit, prostate and urinary considerations, untreated severe obstructive sleep apnea, recent cardiovascular events, thrombosis risk, fertility plans, and other conditions identified through the history.

That review is not a box-checking exercise. It determines whether treatment is appropriate, whether another condition needs attention first, and what monitoring plan is required.

Monitoring is part of the treatment

TRT is not finished when a prescription is written. Follow-up should assess whether symptoms are improving, whether adverse effects are occurring, whether the medication is being used as intended, and whether laboratory findings remain safe.

The exact schedule depends on the formulation, dose, health history, baseline findings, and current guidance.

  • Clinical response and side effects
  • Testosterone level and dosing
  • Blood count and erythrocytosis risk
  • Prostate and urinary monitoring when appropriate
  • Blood pressure, metabolic health, sleep, and cardiovascular context
  • Fertility or testicular concerns
  • Whether the expected benefit still outweighs risk and burden

Real care is more than improving one number

Some men with appropriately diagnosed hypogonadism may benefit from testosterone therapy. Others need treatment of a reversible contributor, a different medical pathway, or referral to endocrinology, urology, sleep medicine, cardiology, or reproductive urology.

At SANE.Medical in Navarre, the goal is not to sell testosterone to every man with fatigue. It is to clarify what the symptoms and data actually support, explain the options, and provide an ongoing medical relationship when treatment is appropriate.

Clinical sources

These sources support the general education above. Individual recommendations depend on your history and current guidance.

Endocrine Society: 2026 Statement on Testosterone Replacement Therapy ↗Endocrine Society: Testosterone Therapy for Hypogonadism Guideline ↗Endocrine Society: Hypogonadism in Men ↗
Dr. Amanda Davis

About the author

Dr. Amanda Davis, DNP, FNP-C

Board-certified family nurse practitioner and founder of SANE.Medical, bringing emergency, trauma, forensic, and whole-body clinical perspective into clear, safety-rooted care.

Meet Dr. Davis →